✨ 10 results found - Searched 22815 records in 4ms.
Tesis
Hubungan kadar vascular endothelial growth factor (VEGF) cairan pleura pada kanker paru karsinoma bukan sel kecil terhadap respons terapi
2025 | BY Sita Laksmi Andarini - Jamal Zaini - Fitriani Muchtar- The Relationship between Pleural Fluid Vascular Endothelial Growth Factor (VEGF) levels in Non-Small Cell Lung Cancer and Response Therapy.
- Nomor Panggil T25362fk
Tesis
Kesintasan Pada Kanker Paru Karsinoma Bukan Sel Kecil Jenis Adenokarsinoma Dengan Mutasi Epidermal Growth Factor Receptor Yang Diterapi Dengan Tyrosin Kinase Inhibitor Selama ≥ 18 Bulan Dan Faktor-Faktor Yang Memengaruhinya Di Rumah Sakit Umum Pusat Persahabatan
2024 | BY Vira Weldimira - Sita Laksmi Andarini - Jamal Zaini- Survival in non-small cell carcinoma lung cancer of adenocarcinoma type with epidermal growth factor receptor mutation treated with tyrosine kinase inhibitors for ≥ 18 months and influencing factors at RSUP Persahabatan.
- Nomor Panggil T24614fk
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
Tesis
Analisis terapi afatinib pada adenokarsinoma paru dengan mutasi epidermal growth factor receptor (EGFR) di RSUP Persahabatan
2023 | BY Widya Angasreni - Sita Laksmi Andarini - Jamal Zaini- Therapy Analysis of afatinib in lung adenocarcinoma with epidermal growth factor receptor mutation (EGFR) at Persahabatan Hospital.
- Nomor Panggil T23185fk
Tesis
Profil dan Angka Tahan Hidup 1 tahun Kanker Paru Bukan Sel Kecil (KPKBSK) Jenis Adenokarsinoma Paru dengan Mutasi Epidermal Growth Factor Receptor (EGFR) Exon 20 T790M Primer di RSUP Persahabatan
2018 | BY Hapsari Retno Dewanti - Sita Laksmi Andarini - Jamal Zaini- The Characteristics and One Year Survival of Lung Adenocarcinoma Patients with Primary Exon 20 T790M Epidermal Growth Factor Receptor Mutation Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T18468fk
Tesis
Angka tahan hidup pasien kangker paru kelompok bukan sel kecil non skuamosa yang mendapat terapi target Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor dan yang mendapat Kemoterapi lini pertama di Rumah sakit Persahabatan
2014 | BY Sita Laksmi Andarini - Kasum Supriadi - Achmad Hudoyo- The survival rate of nonsquamous by non small cell lung carcinoma patiens who are given by target therapy epidermal growth facttor receptor-tyrosin kinase inhibitors and those given by first-line kemotheraphy treatment at Persahabatan hospital.
- Nomor Panggil T14579fk
Tesis
Profil Efikasi dan Toksisitas Terapi Target Baru Golongan Epidermal Factor Receptor-Tyrosine Kinase Inhibitor (EGFRTKi)Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil Non Skuamosa Dengan Mutasi EGFR Positif Dibandingkan Dengan Kemoradioterapi Pada EGFR Wild Type
2014 | BY Sita Laksmi Andarini - Wiendo Syah Putra Yahya - Achmad Hudoyo - Ahmad Utomo- Profile of Efficacy and Toxicity The New Targeted Therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in Non Small Cell Lung Cancer Non-Squamous With Mutated EGFR Compared With Chemoradiotherapy In Wild Type
- Nomor Panggil T14533fk
Tesis
Profil Mutasi Epidermal Growth Factor Receptor dan Angka Tahan Hidup Pasien Adenokarsinoma Paru Usia Muda
2016 | BY Sita Laksmi Andarini - Mia Elhidsi - Achmad Hudoyo- Profile of Epidermal Growth Factor Receptor Mutation and Survival in Young Patients with Lung Adenocarcinoma .
- Nomor Panggil T16330FK
Tesis
Peran quiescent lung cancer stem cell (CSC) dalam proses resistans terhadap agen epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) pada adenokarsinoma paru dengan mutasi EGFR positif
2020 | BY Moulid Hidayat - Sita Laksmi Andarini - Fumiyuki Takahashi- Role of quiescent lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) resistance in EGFR-mutant lung adenocarcinoma.
- Nomor Panggil T20481fk
Tesis
Peran interleukin 1 alpha dalam mekanisme resitansi terhadap osimertinib pada adenokarsinoma paru
2024 | BY Wira Winardi - Kazuhisa Takahashi - Sita Laksmi Andarini - Fariz Nurwidya- The Role of interleukin 1 alpha in resitant mechanism to osimertinib in lung adenocarcinoma.
- Nomor Panggil T24616fk